Author/Authors :
Ryosuke Muroyama، نويسنده , , Naoya Kato، نويسنده , , Haruhiko Yoshida، نويسنده , , Motoyuki Otsuka، نويسنده , , Masaru Moriyama، نويسنده , , Yue Wang، نويسنده , , Run-Xuan Shao، نويسنده , , Narayan Dharel، نويسنده , , Yasuo Tanaka، نويسنده , , Miki Ohta، نويسنده , , Ryosuke Tateishi، نويسنده , , Shuichiro Shiina، نويسنده , , Masashi Tatsukawa، نويسنده , , Kenichi Fukai، نويسنده , , Fumio Imazeki، نويسنده , , Osamu Yokosuka، نويسنده , , Yasush، نويسنده ,
Abstract :
Background/Aims
The hepatitis B virus (HBV) genotype C is associated with the development of hepatocellular carcinoma (HCC). In addition, the HBV X gene, which encodes the pleiotropic transactivator HBx, has also been associated with the development of HCC. In this study, we investigated whether nucleotide changes in the X gene of genotype C are associated with the development of HCC.
Methods/Results
We sequenced the X gene in age- and sex-matched 39 HBV-infected patients with HCC and 36 HBV-infected patients without HCC. A novel nucleotide change that resulted in a proline to serine substitution at codon 38 in HBx (codon-38 change) was preferentially found in patients with HCC. Then, sera were collected from a new group of age- and sex-matched 52 patients with HCC and 51 patients without HCC. In this cohort also, the codon-38 change was associated with HCC. Multiple logistic regression analysis showed the prevalence of the codon-38 change was significantly associated with HCC in all patients (P = 0.001, odds ratio: 4.89).
Conclusion
The codon-38 change in genotype C is an independent risk factor for the development of HCC and may serve as a useful molecular marker for predicting the clinical outcomes in patients infected with HBV
Keywords :
carcinogenesis , multivariate analysis , case-control study , Mutation